Is Diclofenac diethylamine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 6 valid registrations of Diclofenac diethylamine, including Avotrene Emulgel (1 %, Gel, SAR 7.20); DICLOGESIC (1 %, Gel, SAR 7.80); RUMAFEN 1% gel (1 %, Gel, SAR 24.70); VOLTAREN EMULGEL 1% (1 %, Gel, SAR 26.00); Voltaren12 hours Emulgel (2.32 %, Gel, SAR 58.50).

Active substance

Diclofenac diethylamine

SFDA 8
Health Canada 5

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Avotrene Emulgel	1 %	Gel · Topical	50 Tube	SAR 7.20	Generic · OTC	Middle East Pharmaceutical Industries Co Ltd Avalon Pharma	Valid
DICLOGESIC	1 %	Gel · Topical	1 Tube	SAR 7.80	Generic · OTC	DAR ALDAWA	Valid
RUMAFEN 1% gel	1 %	Gel · Topical	1 Tube	SAR 24.70	Generic · OTC	RIYADH PHARMA	Valid
VOLTAREN EMULGEL 1%	1 %	Gel · Topical	1 Tube	SAR 26.00	NCE · OTC	Haleon Schweiz AG	Valid
VOLTAREN EMULGEL 1%	1 %	Gel · Topical	1 Tube	SAR 17.05	NCE · OTC	Haleon Schweiz AG	Valid
Voltaren12 hours Emulgel	2.32 %	Gel · Topical	1 Tube	SAR 58.50	NCE · OTC	Haleon Schweiz AG	Valid
LOCAGEL	1 %	Gel · Topical	1 Tube	SAR 4.40	Generic · OTC	HAYAT PHARMACEUTICAL INDUSTRIES	Withdrawn by MAH · Not Marketed
RUMAFEN 1% gel	1 %	Gel · Topical	1 Tube	SAR 7.05	Generic · OTC	RIYADH PHARMA	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

LOW BACK PAIN; OSTEOARTHRITIS; PAIN MANAGEMENT IN CANCER PATIENTS; POSTOPERATIVE PAIN

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
VOLTAREN EMULGEL ACTIVE	02554801	1.16 % / W/W	GEL · TOPICAL	HALEON CANADA ULC
VOLTAREN EMULGEL BACK & MUSCLE PAIN	02465035	1.16 % / W/W	GEL · TOPICAL	HALEON CANADA ULC
VOLTAREN EMULGEL EXTRA STRENGTH	02393190	2.32 % / W/W	GEL · TOPICAL	HALEON CANADA ULC
VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH	02465043	2.32 % / W/W	GEL · TOPICAL	HALEON CANADA ULC
VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH	02338580	1.16 % / W/W	GEL · TOPICAL	HALEON CANADA ULC

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.